Bayer launches LifeHub UK focused on AI for drug discovery

Bayer has launched LifeHub UK to accelerate and optimize disease detection and data-driven drug discovery by developing ...

October 11, 2019 | Friday | News
Novo Nordisk, bluebird bio plan next-gen in vivo genome editing

US headquartered bluebird bio, Inc. and Denmark based Novo Nordisk have announced that they have entered into a three-ye...

October 11, 2019 | Friday | News
Noble Prize in Medicine 2019 for US, UK scientists

The Nobel Prize in Physiology or Medicine for 2019 has been jointly awarded to three winners, William G. Kaelin Jr., Pet...

October 7, 2019 | Monday | News
Study: High lead levels during pregnancy linked to child obesity

Children born to women who have high blood levels of lead are more likely be overweight or obese, compared to those whos...

October 4, 2019 | Friday | Analysis
Scientists in UK identify cause of antibiotic resistance

Scientists have confirmed for the first time that bacteria can change form to avoid being detected by antibiotics in the...

October 4, 2019 | Friday | News
Novartis and Microsoft to transform medicine with AI

Novartis has announced an important step in reimagining medicine by founding the Novartis AI innovation lab and by selec...

October 3, 2019 | Thursday | News
AstraZeneca divests rights for Losec to Cheplapharm

AstraZeneca, a global, science-led biopharmaceutical company has agreed to sell the global commercial rights, excluding ...

October 3, 2019 | Thursday | News
WHO launches app to improve elderly care

On the International Day of Older Persons – 1 October – the World Health Organization (WHO) has la...

October 2, 2019 | Wednesday | News
PharmaVentures establishes an International Advisory Board

UK based PharmaVentures is pleased to announce the establishment of a new International Advisory Board, comprised of pha...

September 30, 2019 | Monday | News
Kaspersky updates decryption tool to fight ransomware pair

Ransomware is a dangerous threat to healthcare consumers and businesses, with new types of malware being developed rapid...

September 30, 2019 | Monday | News
High drug costs despite public R&D funding in the millions

Ludwig Boltzmann Institute for Health Technology Assessment (Vienna, Austria) identifies public funding for the developm...

September 30, 2019 | Monday | Analysis
NIH awards contracts to advance tuberculosis immunology research

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarde...

September 27, 2019 | Friday | News
Guerbet and IBM Watson Health leverage AI for medical imaging

France based Guerbet, a global specialist in contrast agents and solutions for diagnostic and interventional medical ima...

September 25, 2019 | Wednesday | News
Enesi Pharma secures innovate UK funding to manufacture ImplaVax

Enesi Pharma ("Enesi"), the innovative pharmaceutical company developing unique injectable solid dose drug-device vaccin...

September 24, 2019 | Tuesday | News
Countries must invest at least 1% more of GDP on primary health care: WHO

Countries must increase spending on primary healthcare by at least 1% of their gross domestic product (GDP) if the world...

September 24, 2019 | Tuesday | News
OPTIMA innovations to provide solutions for aseptic API processing

At P-Mec, the experts from Optima Pharma and Optima Life Science will be presenting new technologies and an extensive ra...

September 24, 2019 | Tuesday | News
Novo Nordisk set to bring innovative treatment for type 2 diabetes

Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved Rybelsus® (semaglutide) ta...

September 23, 2019 | Monday | News
WCG KMR group invites Biopharma companies to enroll in Clinical Trial Cost Study

The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division announced on 17 Sep 2019 that the enrolme...

September 20, 2019 | Friday | News